
STAT+: Differences in countries’ regulations keep some cell and gene therapies from reaching patients
CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]